| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.002 | 1 |